Mutations in ADAR2 increase global A-to-I RNA editing levels in oncogenes and TSGs, introducing a mutation-ADAR2-UES-oncogene/TSG-HCC axis. This evidence concerns the gene ADARB1 and hepatocellular carcinoma.